慢性肺部疾病的鼻腔治疗
1National Heart and Lung Institute, Imperial College, London, United Kingdom.
细胞衰老驱动慢性肺部疾病,如COPD和IPF. 疗法,使用形药和解药,在治疗这些疾病方面表现有前途,目前正在临床试验中.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 老年学是指老年学的学科.
背景情况:
- 慢性呼吸道疾病是全球主要的死亡原因.
- 由氧化应激和DNA损伤驱动的细胞衰老加速肺衰老和疾病进展.
- 在衰老的肺部观察到降低的抗衰老分子,如sirtuins的水平.
研究的目的:
- 探索细胞衰老作为慢性肺病的关键机制.
- 审查老年疗法作为一种针对衰老细胞的新型治疗策略.
- 讨论老态和老化药物类别及其治疗潜力.
主要方法:
- 审查证据,将细胞衰老与慢性肺部疾病联系起来.
- 对老年疗法机制的分析,包括老年形和老年化药物.
- 对老年疗法的临床前和临床试验数据的检查.
主要成果:
- 细胞衰老及其相关的分泌表型与COPD和IPF有关.
- 老年疗法,包括老年化药物 (例如,mTOR 抑制剂,抗氧化剂,Sirtuin 激活剂) 和老年化药物 (例如,BCL-XL 抑制剂,心脏糖化物),已在动物模型中显示出有效性.
- 几种老年疗法正在进行呼吸系统疾病的临床试验.
结论:
- 细胞衰老是慢性肺病进展的关键驱动因素.
- 疗是治疗衰弱性呼吸道疾病的一个有前途的治疗途径.
- 需要进一步研究老年疗法的长期安全性和有效性.
更多相关视频
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
